EUVIMED · CrossrefZeitschrift
Therapeutic Innovation & Regulatory Science
ISSN 2168-4790 · Springer Science and Business Media LLC
Neueste Artikel
Quality by Design in Adaptive Oncology Clinical Trials: A Conceptual and Inspection-Focused Review
Aligning National Registries with the WHO Model List of Essential Medicines for Children: Policy Barriers and Pediatric Formulation Gaps in Selected European Countries
Distributed Conduct, Concentrated Accountability: When Principal-Investigator Oversight Outruns Authority and Capacity
Public Participation in U.S. Food and Drug Administration (FDA) Advisory Committees: A Qualitative Analysis
Career Paths to Drug Development and Regulatory Science Through the U.S. Food and Drug Administration
Integral Drug-Device Combinations and Medical Device Regulation Article 117: The European Medicines Agency Perspective
BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity
Schizophrenia Impacts and Treatment Priorities: Results of An Externally-Led Patient-Focused Drug Development Meeting Survey
Understanding the Added Value of Action Limits for QTL Monitoring
35 Years of GLP in Germany: A Brief Overview About Its Successful History
Different Clinical Questions Need Different Estimands
Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough
Guidance on Transparent Sponsorship Reporting in Industry Associated Delphi Studies (TRIAD): Recommendations Based on a Systematic Review
Association Between FDA Drug Recall Classification and Product-Related Characteristics
Analysis of Serious Breach Cases Reported in the EU Clinical Trials Information System: Quantitative and Qualitative Assessment
FDA Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites: Testing Presence, Prominence, and Wording
Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece
How Digital Health Technologies have been Used to Support Regulatory Drug Approval
Methods for Assessing Therapeutic Innovation of Drugs: Changes at the Italian Medicine Agency
Application of the Child–Pugh Classification in Japanese Drug Labeling: A Cross-Sectional Analysis of Contraindications, Dose Recommendations, and Pharmacokinetic Rationale
Quality by Design to Mitigate Aggregation: Mechanistic Insights and Analytical Strategies for Biopharmaceutical Manufacturing
Defining a Clinically Meaningful Within-Person Change Threshold for the Psychomotor Vigilance Test in Narcolepsy Type 1
Regulatory Alignment on Surrogate Endpoints for Slowly Progressive Ultra-Rare Neurological Diseases: Bridging the Gap Between Biomarker Science and Global Regulatory Acceptance
Effects of Generic Prednisolone Formulations on the Dissolution Behavior of Mycophenolate Mofetil under Various pH Conditions
Key Real-World Data Management Practices for Registry Evaluation and Quality Assurance
Psychotropic Drug Scheduling and Benzodiazepine Receptor Agonist Prescribing in Japan: An Interrupted Time Series Analysis
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need
The Changing Landscape of Global Biopharmaceutical Leadership, 2004–2024
Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning
Precision Lipid Management in the Era of Biotechnology and Artificial Intelligence: From Gene Editing to Smart Drug Delivery
EUVIMED